FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...